Literature DB >> 33161106

LncRNA OIP5-AS1 reduces α-synuclein aggregation and toxicity by targeting miR-126 to activate PLK2 in human neuroblastoma SH-SY5Y cells.

Zhiwei Song1, Baoming Xie2.   

Abstract

It has been reported that many long noncoding RNAs (lncRNA) are abnormally expressed in Parkinson's disease (PD). However, the knowledge about the role of dysregulated lncRNA in the pathological process of PD and the potential molecular regulation mechanism is still limited. Our immunofluorescence data show that miR-126 enhances the aggregation and toxicity of synuclein, while lncRNA OIP5-AS1 reduces the aggregation and toxicity of MPP + induced α-synuclein by targeting miR-126. Luciferase experiments have found that miR-126 regulates α-synuclein by targeting PLK2. Western blot and IP experimental analysis showed that this process is achieved by regulating PLK2/α-synuclein autophagy. In conclusion, our data indicate that OIP5-AS1 promotes the autophagy of PLK2-α-synuclein by targeting the miR-126 axis with pathogenic factors, thus reducing the aggregation toxicity of α-synuclein, which It will help better to understand the mechanism of dopaminergic neuron loss in PD and provide novel treatment options.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; OIP5-AS1; SH-SY5Y cells; miR-126; α-synuclein

Mesh:

Substances:

Year:  2020        PMID: 33161106     DOI: 10.1016/j.neulet.2020.135482

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  The role of lncRNA OIP5-AS1 in cancer development and progression.

Authors:  Cheng Zheng; Man Chu; Qiuli Chen; Cheng Chen; Zhi-Wei Wang; Xiao Chen
Journal:  Apoptosis       Date:  2022-03-22       Impact factor: 4.677

2.  Dysregulation of Circulatory Levels of lncRNAs in Parkinson's Disease.

Authors:  Jin-Ying Zhao; Rong-Rong Pan; Teng Jiang; Ting Huang; Xin-Xin Fu; Qing Huang; Xi-Xi Wang; Peng-Yu Gong; You-Yong Tian; Ying-Dong Zhang
Journal:  Mol Neurobiol       Date:  2022-10-20       Impact factor: 5.682

Review 3.  Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases.

Authors:  Giulia Gentile; Giovanna Morello; Valentina La Cognata; Maria Guarnaccia; Francesca Luisa Conforti; Sebastiano Cavallaro
Journal:  J Pers Med       Date:  2022-05-10

4.  Long non-coding RNA NHEG1/hsa-miR-665/HMGB1 axis is involved in the regulation of neuroblastoma progression.

Authors:  Yuqing Zhang; Yuping Hu; Aihong Pan; Lei He; Jin Wang; Fangfang Zhou; Yongbo Lei; Yuanyuan Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 5.  Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson's disease.

Authors:  Hantao Zhang; Xiaoyan Liu; Yi Liu; Junlin Liu; Xun Gong; Gang Li; Min Tang
Journal:  Front Aging Neurosci       Date:  2022-08-09       Impact factor: 5.702

Review 6.  The Role of Non-Coding RNAs in the Pathogenesis of Parkinson's Disease: Recent Advancement.

Authors:  Hanwen Zhang; Longping Yao; Zijian Zheng; Sumeyye Koc; Guohui Lu
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-30

Review 7.  Long non-coding RNA OIP5-AS1 (Cyrano): A context-specific regulator of normal and disease processes.

Authors:  Serena Wooten; Keriayn N Smith
Journal:  Clin Transl Med       Date:  2022-01

8.  LncRNA OIP5-AS1 Promotes the Autophagy-Related Imatinib Resistance in Chronic Myeloid Leukemia Cells by Regulating miR-30e-5p/ATG12 Axis.

Authors:  Hongdan Dai; Jianming Wang; Zhenglan Huang; Hui Zhang; Xin Wang; Qian Li; Wenli Feng
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.